欢迎您, 登录 | 注册

首页 | English

X
加载中

Osteosarcomas are the most common primary, non-hematologic malignant tumors in childhood and adolescence, comprising almost 60% of all bone sarcomas. Although these tumors are osteoblastic in nature, the characteristics of the specific tumor-initiating cells are unclear. Osteosarcomas contain highly proliferative undifferentiated malignant cells with a disrupted bone differentiation program. Cancer stem cells (CSCs) that have tumor-initiating properties and capacity of symmetric and asymmetric division have now been described in many solid tumors. For osteosarcomas, the CSC hypothesis has received support from recently reported findings that both human and murine osteosarcomas contain a sub-population of multipotent cells that that express various mesenchymal stem cell surface markers and are capable of undergoing differentiation in multiple mesenchymal lineages such as osteoblasts and adipocytes. Differentiation into these different lineages can be easily assessed by growing cells in specific medium and assaying for differentiation markers.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Osteogenic and Adipogenic Differentiation of Osteosarcoma Cells
骨肉瘤细胞的成骨和生脂分化

癌症生物学 > 癌症干细胞 > 细胞生物学试验 > 细胞分离和培养
作者: Upal Basu-Roy
Upal Basu-RoyAffiliation: Department of Microbiology, NYU School of Medicine, New York, USA
For correspondence: upal.basuroy@nyumc.org
Bio-protocol author page: a190
Claudio Basilico
Claudio BasilicoAffiliation: Department of Microbiology, NYU School of Medicine, New York, USA
Bio-protocol author page: a191
 and Alka Mansukhani
Alka MansukhaniAffiliation: Department of Microbiology, NYU School of Medicine, New York, USA
For correspondence: alka.mansukhani@med.nyu.edu
Bio-protocol author page: a192
Vol 2, Iss 24, 12/20/2012, 9742 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.308

[Abstract] Osteosarcomas are the most common primary, non-hematologic malignant tumors in childhood and adolescence, comprising almost 60% of all bone sarcomas. Although these tumors are osteoblastic in nature, the characteristics of the specific tumor-initiating cells are unclear. Osteosarcomas contain highly proliferative undifferentiated malignant cells with a disrupted bone differentiation program. Cancer stem cells (CSCs) that have tumor-initiating properties and capacity of symmetric and asymmetric division have now been described in many solid tumors. For osteosarcomas, the CSC hypothesis has received support from recently reported findings that both human and murine osteosarcomas contain a sub-population of multipotent cells that that express various mesenchymal stem cell surface markers and are capable of undergoing differentiation in multiple mesenchymal lineages such as osteoblasts and adipocytes. Differentiation into these different lineages can be easily assessed by growing cells in specific medium and assaying for differentiation markers.

Materials and Reagents

  1. Osteosarcoma cells (Basu-Roy et al., 2012)
  2. DMEM - high Glucose from Invitrogen (Life Technologies, Invitrogen™, catalog number: 11330-032)
  3. Fetal bovine serum (FBS)
  4. Penicillin-streptomycin
  5. Beta-glycerol phosphate (Sigma-Aldrich, catalog number: G9422)
  6. Ascorbic acid (Sigma-Aldrich, catalog number: A4034)
  7. Earle's balanced salt solution (EBSS) from Invitrogen (Life Technologies, Invitrogen™, catalog number: 14155-063)
  8. HCl
  9. Ethanol
  10. DMSO (Sigma-Aldrich, catalog number: D8418)
  11. Phosphate buffered saline (PBS)
  12. Paraformaldehyde
  13. Isopropanol
  14. Acetone
  15. Double-distilled H2O (ddw)
  16. Citrate concentrated solution (20 ml) (Sigma-Aldrich, catalog number: 854C)
  17. Naphthol AS-MX phosphate alkaline solution, 0.25% (20 ml) (Sigma-Aldrich, catalog number: 855)
  18. COMPLETE capsule of Fast Blue RR salt (Sigma-Aldrich, catalog number: FBS25-10 CAP)
  19. Oil-Red-O (Sigma-Aldrich, catalog number: O0625)
  20. Mayer's HemTox stain (Sigma-Aldrich, catalog number: MHS1)
  21. Alizarin Red S certified by the biological stain commission (Sigma-Aldrich, catalog number: A5533)
  22. Beta-glycerol phosphate stock solution (see Recipes)
  23. 1,000x ascorbic acid solution (see Recipes)
  24. Dexamethasone (Sigma-Aldrich, catalog number: D4902) (see Recipes)
  25. 3-Isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich, catalog number: I5879) (see Recipes)
  26. Indomethacin (Sigma-Aldrich, catalog number: I8280) (see Recipes)
  27. Insulin (recombinant human) (Sigma-Aldrich, catalog number: I2643) (see Recipes)
  28. Fixation solution (see Recipes)
  29. Staining solution for osteogenesis (see Recipes)
  30. Oil-Red-O stock solution (see Recipes)
  31. Staining solution for mineralized osteoblasts (see Recipes)

Equipment

  1. Tissue culture set up
  2. Pasteur pipette
  3. Pasteur pipette tip
  4. Light microscope
  5. Pall Life Sciences acrodisc ayringe filter (0.2 μM HT Tuffryn membrane low-protein binding non-pyogenic) (Life Sciences, catalog number: PN 4192)
  6. 0.2 μM nylon filter
  7. 24-well plates

Procedure

  1. Plating cells for differentiation
    1. Plate 50,000-60,000 osteosarcoma cells per well in 24-well plates in DMEM/10% FBS/ Penicillin-Streptomycin. This can be your cell line of interest too. Change medium according to your cell line of interest.
    2. Next day or when they reach confluence (usually in 36 h), switch medium to differentiation medium. Usually cells will not differentiate unless they are at least 80-90% confluent. All differentiation medium is regular DMEM/10% FBS/PS supplemented with the differentiation cocktail indicated in steps 3 and 4.
    3. For osteogenesis, use 10 mM beta-glycerol phosphate and 100 μg/ml ascorbic acid. These are the final concentrations.
    4. For adipogenesis, use 10 μg/ml Insulin, 100 nM dexamethasone, 250 μM IBMX and 200 μM Indomethacim. These are the final concentrations. How to make stocks is described later.
    5. Feed cells every 2-3 days with fresh differentiation medium made each time during feeding. While feeding make sure Pasteur pipette tip used for aspirating medium does not touch cell layer as cells attach loosely during differentiation, especially during adipogenesis.
    6. Stain cells for osteogenesis and adipogenesis at 2, 5, 8, 10, 12 and 15 days.

  2. Alkaline phosphatase assay to measure osteoblast differentiation.
    This is a colorimetric assay where the yellow substrate. 4-Benzoylamino-2, 5-dimethoxybenzenediazonium chloride hemi (zinc chloride) salt, Azoic Diazo No. 24 is hydrolyzed by alkaline phosphatase to yield a purple dye precipitate.
    Prepare fixation solution and staining solution before starting assay. Protect solutions from light fiter preparation.
    1. Plate required cells in differentiation medium (usually 50,000 cells/well in 24-well plates).
    2. Aspirate off medium from cells plated in differentiation medium at designated time.
    3. Wash once with 1x PBS. Each washing step involved adding 1x PBS followed by aspiration.
    4. Add 1 ml of fixation solution per well and incubate at RT for 1 min.
    5. Wash wells with 1x PBS once.
    6. Add I ml of staining solution per well.
    7. Incubate in the dark for 30 min at RT and check color development. Development of purple-violet stained areas in well indicates positive reaction. If necessary, continue reaction for another 30 min at RT. Record increased incubation time. Do not exceed 1 h.
    8. Stop reaction by washing quickly with dd water or tap water.
    9. Do not forget to photograph plates before proceeding to Alizarin red S staining for mineralization.

  3. Alizarin red S staining to detect mineralization
    Alizarin red S is a calcium-sensing dye. Differentiated osteoblasts deposit large amounts of extracelluar calcium (a hallmark of mineralization) that can be detected by complexing with Alizarin red S. Calcium deposits appear as bright orange-red stained areas.
    1. After photographing the plates stained for alkaline phosphatase, proceed to Alizarin red S staining by washing the stained plated twice with 1x PBS whose pH has been adjusted to 4.2 with 0.1% NH4OH.
    2. Aspirate the PBS and add enough Alizarin red S staining solution to cover the cellular monolayer. Incubate the plate at RT in the dark for 45 min.
    3. Carefully aspirate the Alizarin red S solution and wash the plate fours time wits distilled water.
    4. Extracellular calcium deposits appear as brightly stained orange-red areas.

  4. Oil red O staining assay to measure adipogenic differentiation
    This staining assay is based on the principle that the lipophilic dye Oil Red O is retained in fat globules of adipocytes that can be seen under a microscope.
    1. Aspirate medium and wash cells once in PBS.
    2. Fix cells in 4% PFA at RT for 15 min.
    3. Wash twice with ddH2O for 2 x 5 min.
    4. Stain with Oil-Red-O working solution for 15 min at RT.
    5. Wash with 1x PBS or ddH2O for 3 x 5 min.
    6. Rinse cells with 50% isopropanol once at RT.
    7. Rinse cells with 1x PBS or ddH2O.
    8. The red stained lipid droplets can be visualized by light microscopy. The adipocytes are also readily visualized in normal microscopy through their rounded morphology and markedly enhanced light reflection of larger lipid droplets.
    9. To count total cells, stain with Mayer's HemTox stain for 15 min at RT and wash 2x with dd water.

Recipes

  1. Beta-glycerol phosphate can be prepared by making a 100x stock of 1 M solution. Pre-heat water for ease of dissolution. The formula weight of the compound depends on the degree of hydration and can be determined by using the Lot Number provided on the bottle. Filter using a Pall Life Sciences Acrodisc syringe filter. Make 1 ml aliquots and freeze in -20 °C.
  2. 1,000x ascorbic acid solution can be prepared by dissolving 1 gram of Ascorbic acid in 10 ml of ddw (double-distilled water). Filter using a Pall Life Sciences Acrodisc Syringe filter. Make 1 ml aliquots and freeze in -20 °C.
  3. Dexamethasone (FW 392.5)
    Dissolve 0.0196 g in 10 ml absolute ethanol to yield 5 mM stock; store at -80 °C. Prepare fresh working stock by diluting in 100% ethanol to 100 μM.
  4. 3-Isobutyl-1-methylxanthine (IBMX) (FW 222.2)
    Dissolve 100 mg IBMX in 1.8 ml DMSO and sterile filter through 0.2 μM nylon filter to make 250 mM stock (1,000x). Aliquot and store at -20 °C or below.
  5. Indomethacin (FW 357.8)
    Dissolve 0.5367 g indomethacin in 7.5 ml DMSO, and filter through 0.2 μm nylon filter to sterilize for 200 mM (1,000x) stock. Dispense 1-2 ml aliquots in sterile cryovials, and store in opaque box to protect from light. Store at -70 °C or below.
  6. Insulin, recombinant human
    Dissolve 50 mg insulin in 10 ml EBSS acidified with 50 μl of 0.005 N HCl to yield 500x stock, and sterile filter. Do not forget to use low protein binding filters, as described in equipment. Dispense 1 ml aliquots in sterile cryovials and store at -70 °C or below for up to 2 years. Thawed, working stock can be stored at 4 °C for up to 1 month. Alternatively, sterile-filter acidified EBSS and use the sterile solution to make insulin under sterile conditions.
  7. Fixation solution for osteogenesis
    20 ml dd water + 30 ml acetone + 400 μl citrate concentrated solution.
  8. Staining solution for osteogenesis
    48 ml dd water + 2 ml Naphthol AS-MX phosphate alkaline solution, 0.25% + 1 complete capsule of fast blue RR salt
  9. Oil-Red-O stock solution for staining adipocytes
    Dissolve 500 mg of Oil-Red-O in 100 ml of isopropanol. For working stock, dilute stock as 2 parts dd water + 3 parts Oil Red O stock. Shake, Incubate at RT for 15 min and filter using a Pall Life Sciences Acrodisc Syringe filter. Use within 1 h of preparation.
  10. Staining solution for mineralized osteoblasts
    Dissolve 2 g Alizarin Red S in 100 ml distilled water, mix, and adjust pH to 4.2 with 0.1% NH4OH to prepare the Alizarin Red S staining solution. Filter the dark-brown solution using a using a Pall Life Sciences Acrodisc Syringe filter. And store it in the dark in a foil-covered or amber colored bottle.
    Note: The correct pH of the solution is critical. The solution is stable at RT for 2-3 weeks. If you plan on using it after a month, check pH to ensure pH is still 4.2.

Acknowledgments

This investigation was supported by PHS Grants AR051358 from the NIAMS and DE013745 from the NIDCR, and by an NCI UO1 award (to SHO). UBR is a recipient of a fellowship from The Children's Cancer Research Fund in memory of Dr A Rausen. AM is a recipient of a research grant from St Baldrick's Foundation. JAP is a postdoctoral fellow of the American Cancer Society. SHO is an Investigator of the Howard Hughes Medical Institute. This protocol is associated with the manuscript Basu-Roy et al. (2012).

References

  1. Basu-Roy, U., Seo, E., Ramanathapuram, L., Rapp, T. B., Perry, J. A., Orkin, S. H., Mansukhani, A. and Basilico, C. (2012). Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene 31(18): 2270-2282.


How to cite this protocol: Basu-Roy, U., Basilico, C. and Mansukhani, A. (2012). Osteogenic and Adipogenic Differentiation of Osteosarcoma Cells. Bio-protocol 2(24): e308. DOI: 10.21769/BioProtoc.308; Full Text



可重复性反馈:

  • 添加图片
  • 添加视频

我们的目标是让重复别人的实验变得更轻松,如果您已经使用过本实验方案,欢迎您做出评价。我们鼓励上传实验图片或视频与小伙伴们(同行)分享您的实验心得和经验。(评论前请登录)

问题&解答:

  • 添加图片
  • 添加视频

(提问前,请先登陆)bio-protocol作为媒介平台,会将您的问题转发给作者,并将作者的回复发送至您的邮箱(在bio-protocol注册时所用的邮箱)。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片或者视频的形式来说明遇到的问题。由于本平台用Youtube储存、播放视频,作者需要google 账户来上传视频。


登陆 | 注册
分享
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook
Upal Basu-Roy的其他实验方案(1)
Claudio Basilico的其他实验方案(1)
Alka Mansukhani的其他实验方案(1)